Compounds > vancomycin

Page last updated: 2024-08-21

vancomycin and Hearing Loss

vancomycin has been researched along with Hearing Loss in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (5.56)	18.7374
1990's	4 (22.22)	18.2507
2000's	5 (27.78)	29.6817
2010's	7 (38.89)	24.3611
2020's	1 (5.56)	2.80

Authors

Authors	Studies
Bitner-Glindzicz, M; Chant, K; Marlow, N	1
Humphrey, C; Shorman, MA; Veve, MP; Walker, B	1
Burmistrova, DS; D'yakonova, IN; Ishanova, YS; Kamkina, OV; Rakhmanova, IV	1
Heath, PT; Hill, LF; Lestner, JM; Sharland, M	1
Carroll, K; Cohen, DM; Cross, CP; Feeney, MP; Garinis, AC; Gold, JA; Hunter, LL; Keefe, DH; Putterman, DB; Srikanth, P; Steyger, PS	1
Jackson, MA; Mann, K	1
Martello, JL; Potoski, BA; Shields, RK	1
Kocyigit, I; Oymak, O; Sipahioglu, MH; Somdas, MA; Tokgoz, B; Ucar, C; Unal, A; Utas, C	1
Begg, EJ; Borrie, TL; Darlow, BA; Lynn, AM; Robertshawe, BJ; Vella-Brincat, JW	1
de Hoog, M; Hop, WC; Overbosch, E; van den Anker, JN; van Zanten, BA; Weisglas-Kuperus, N	1
LEACH, W	1
Diao, M; Du, L; Gao, W; Han, H; Liu, H; Zhang, S; Zhang, Y	1
Forgie, SE; Joffe, AR; Lee, BE; Robinson, JL; Vaudry, WL	1
Cantú, TG; Lietman, PS; Yamanaka-Yuen, NA	1
Moellering, RC	1
Cobo, J	1
Perman, E	1

Reviews

5 review(s) available for vancomycin and Hearing Loss

Article	Year
Drug-induced hearing loss. Prescrire international, 2014, Volume: 23, Issue:155 Topics: Aminoglycosides; Anti-Infective Agents; Antineoplastic Agents; Dose-Response Relationship, Drug; Hearing Loss; Humans; Vancomycin	2014
Vancomycin toxicity in neonates: a review of the evidence. Current opinion in infectious diseases, 2016, Volume: 29, Issue:3 Topics: Acute Kidney Injury; Adult; Animals; Anti-Bacterial Agents; Child; Disease Models, Animal; Gram-Positive Bacterial Infections; Hearing Loss; Humans; Infant, Newborn; Mice; Vancomycin	2016
Serum vancomycin concentrations: reappraisal of their clinical value. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:4 Topics: Bacterial Infections; Clinical Trials as Topic; Hearing Loss; Humans; Kidney; Vancomycin	1994
Monitoring serum vancomycin levels: climbing the mountain because it is there? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:4 Topics: Bacterial Infections; Hearing Loss; Humans; Kidney; Vancomycin	1994
[Vancomycin and teicoplanin: differential aspects]. Enfermedades infecciosas y microbiologia clinica, 1995, Volume: 13, Issue:10 Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythema; Gram-Positive Bacterial Infections; Hearing Loss; Humans; Incidence; Infusions, Intravenous; Kidney Diseases; Prospective Studies; Teicoplanin; Vancomycin	1995

Other Studies

13 other study(ies) available for vancomycin and Hearing Loss

Article	Year
Cumulative risk factors contributing to hearing loss in preterm infants. Archives of disease in childhood. Fetal and neonatal edition, 2023, Volume: 108, Issue:5 Topics: Case-Control Studies; Child; Deafness; Furosemide; Gentamicins; Hearing Loss; Humans; Infant; Infant, Newborn; Infant, Premature; Risk Factors; Vancomycin	2023
Long-term vancomycin use had low risk of ototoxicity. PloS one, 2019, Volume: 14, Issue:11 Topics: Adult; Anti-Bacterial Agents; Audiometry; Cross-Sectional Studies; Electronic Health Records; Female; Follow-Up Studies; Hearing Loss; Humans; Male; Middle Aged; Ototoxicity; Prevalence; Prospective Studies; Retrospective Studies; Vancomycin	2019
Auditory Function in Immature Animals after Two Consecutive Courses of Ototoxic Antibiotics. Bulletin of experimental biology and medicine, 2015, Volume: 159, Issue:4 Topics: Acoustic Stimulation; Animals; Anti-Bacterial Agents; Drug Administration Schedule; Evoked Potentials, Auditory, Brain Stem; Gentamicins; Hearing Loss; Otoacoustic Emissions, Spontaneous; Rabbits; Vancomycin	2015
The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2017, Volume: 16, Issue:3 Topics: Adolescent; Adult; Age Factors; Amikacin; Anti-Bacterial Agents; Audiometry, Pure-Tone; Bacterial Infections; Cystic Fibrosis; Female; Hearing Loss; Humans; Male; Middle Aged; Patient Outcome Assessment; Sex Factors; Time; Tobramycin; United States; Vancomycin	2017
Meningitis. Pediatrics in review, 2008, Volume: 29, Issue:12 Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Drug Therapy, Combination; Hearing Loss; Humans; Incidence; Infant; Intracranial Hypertension; Meningitis; Meningitis, Bacterial; Meningitis, Meningococcal; Vancomycin	2008
Is vancomycin ototoxicity a significant risk? Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10 Topics: Age Factors; Anti-Bacterial Agents; Audiometry; Case-Control Studies; Female; Hearing Disorders; Hearing Loss; Humans; Male; Regression Analysis; Retrospective Studies; Vancomycin	2009
Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD. Renal failure, 2010, Volume: 32, Issue:2 Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Audiometry, Pure-Tone; Case-Control Studies; Cephalothin; Female; Hearing Loss; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Regression Analysis; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Vancomycin	2010
Are gentamicin and/or vancomycin associated with ototoxicity in the neonate? A retrospective audit. Neonatology, 2011, Volume: 100, Issue:2 Topics: Anti-Bacterial Agents; Clinical Audit; Cochlear Implants; Dose-Response Relationship, Drug; Gentamicins; Hearing Loss; Hearing Tests; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Retrospective Studies; Risk Factors; Sepsis; Vancomycin	2011
Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss. The Journal of pediatrics, 2003, Volume: 142, Issue:1 Topics: Anti-Bacterial Agents; Audiometry; Dose-Response Relationship, Drug; Drug Administration Schedule; Evoked Potentials, Auditory, Brain Stem; Hearing Loss; Humans; Infant, Newborn; Neonatal Screening; Risk Factors; Tobramycin; Vancomycin	2003
Ototoxicity of neomycin and other antibiotics. The Journal of laryngology and otology, 1962, Volume: 76 Topics: Anti-Bacterial Agents; Deafness; Ear; Hearing Loss; Kanamycin; Neomycin; Polymyxins; Ristocetin; Streptomycin; Vancomycin; Viomycin	1962
Ototoxicity of a new glycopeptide, norvancomycin with multiple intravenous administrations in guinea pigs. The Journal of antibiotics, 2004, Volume: 57, Issue:1 Topics: Animals; Anti-Bacterial Agents; Cell Count; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hair Cells, Auditory; Hearing Loss; Injections, Intraperitoneal; Injections, Intravenous; Microscopy, Electron, Scanning; Nystagmus, Physiologic; Organ of Corti; Vancomycin	2004
Could hearing loss be related to delay in administration of other antibiotics rather than early use of vancomycin? Pediatrics, 2007, Volume: 119, Issue:2 Topics: Anti-Bacterial Agents; Hearing Loss; Humans; Infant; Time Factors; Vancomycin	2007
["Sudden deafness" has not been classified as a side-effect. No compensation from the Drug Insurance Authority]. Lakartidningen, 1999, Mar-10, Volume: 96, Issue:10 Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Female; Hearing Loss; Hearing Loss, Sudden; Humans; Indomethacin; Insurance Claim Review; Male; Middle Aged; Vancomycin	1999